Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

about

A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level.Pediatric Glioma at the Optic Pathway and Thalamus.

P2860

Q33428049-BA2F131C-D454-400D-BA72-CB0F770DEAE9 Q38973191-5A4602B6-BA53-4806-B299-6149758F56C5 Q55333228-7980420E-0049-464C-81FD-743DD5D1A87E

P2860

Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

Item

http://www.wikidata.org/entity/Q38074880

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

@en

type

Item

label

Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

@en

prefLabel

Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

@en

P1476

Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

@en

P2093

David Franz

http://www.w3.org/2001/XMLSchema#string

Lionel M Chow

http://www.w3.org/2001/XMLSchema#string

Trent R Hummel

http://www.w3.org/2001/XMLSchema#string

P2860

The tuberous sclerosis complex

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas

An integrated genomic analysis of human glioblastoma multiforme

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

The 2007 WHO classification of tumours of the central nervous system

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

HES and HERP families: multiple effectors of the Notch signaling pathway

Defining the role of mTOR in cancer

P2888

s40272-012-0002-4

P304

29-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40272-012-0002-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maryam Fouladi

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234161730

http://www.w3.org/2001/XMLSchema#string

P6179

1052178254

http://www.w3.org/2001/XMLSchema#string

P698

23329387

http://www.w3.org/2001/XMLSchema#string

Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

about

P2860

P2860

Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698